HemostOD: platelets on demand
HemostOD, an EPFL start-up supported by Alliance to obtain an Innosuisse grant, has developed an innovative solution for producing platelets ex vivo, enabling large quantities to be generated in a short space of time.
Limula, the company revolutionizing cancer cell therapy
Lausanne-based Limula is revolutionizing cancer cell and gene therapy by simplifying the manufacturing process, thanks to an innovative bioreactor that enables these highly personalized treatments to be produced at scale and on demand.